Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer.

Lane JA, Er V, Avery KNL, Horwood J, Cantwell M, Caro GP, Crozier A, Smith GD, Donovan JL, Down L, Hamdy FC, Gillatt D, Holly J, Macefield R, Moody H, Neal DE, Walsh E, Martin RM, Metcalfe C.

Cancer Prev Res (Phila). 2018 Nov;11(11):687-696. doi: 10.1158/1940-6207.CAPR-18-0147. Epub 2018 Oct 11.

PMID:
30309839
2.

'We all want to succeed, but we've also got to be realistic about what is happening': an ethnographic study of relationships in trial oversight and their impact.

Daykin A, Selman LE, Cramer H, McCann S, Shorter GW, Sydes MR, Gamble C, Macefield R, Lane JA, Shaw A.

Trials. 2017 Dec 22;18(1):612. doi: 10.1186/s13063-017-2305-9.

3.

Development of a single, practical measure of surgical site infection (SSI) for patient report or observer completion.

Macefield RC, Reeves BC, Milne TK, Nicholson A, Blencowe NS, Calvert M, Avery KN, Messenger DE, Bamford R, Pinkney TD, Blazeby JM.

J Infect Prev. 2017 Jul;18(4):170-179. doi: 10.1177/1757177416689724. Epub 2017 Feb 1.

4.

A mixed-methods feasibility and external pilot study to inform a large pragmatic randomised controlled trial of the effects of surgical wound dressing strategies on surgical site infections (Bluebelle Phase B): study protocol for a randomised controlled trial.

Bluebelle Study Group, Reeves BC, Andronis L, Blazeby JM, Blencowe NS, Calvert M, Coast J, Draycott T, Donovan JL, Gooberman-Hill R, Longman RJ, Magill L, Mathers JM, Pinkney TD, Rogers CA, Rooshenas L, Torrance A, Welton NJ, Woodward M, Ashton K, Bera KD, Clayton GL, Culliford LA, Dumville JC, Elliott D, Ellis L, Gould-Brown H, Macefield RC, McMullan C, Pope C, Siassakos D, Strong S, Talbot H.

Trials. 2017 Aug 29;18(1):401. doi: 10.1186/s13063-017-2102-5.

5.

Dressings for the prevention of surgical site infection.

Dumville JC, Gray TA, Walter CJ, Sharp CA, Page T, Macefield R, Blencowe N, Milne TK, Reeves BC, Blazeby J.

Cochrane Database Syst Rev. 2016 Dec 20;12:CD003091. doi: 10.1002/14651858.CD003091.pub4. Review.

PMID:
27996083
6.

'Trial Exegesis': Methods for Synthesizing Clinical and Patient Reported Outcome (PRO) Data in Trials to Inform Clinical Practice. A Systematic Review.

McNair AG, Macefield RC, Blencowe NS, Brookes ST, Blazeby JM.

PLoS One. 2016 Aug 29;11(8):e0160998. doi: 10.1371/journal.pone.0160998. eCollection 2016. Review.

7.

Three nested randomized controlled trials of peer-only or multiple stakeholder group feedback within Delphi surveys during core outcome and information set development.

Brookes ST, Macefield RC, Williamson PR, McNair AG, Potter S, Blencowe NS, Strong S, Blazeby JM.

Trials. 2016 Aug 17;17(1):409. doi: 10.1186/s13063-016-1479-x.

8.

Core Outcomes for Colorectal Cancer Surgery: A Consensus Study.

McNair AG, Whistance RN, Forsythe RO, Macefield R, Rees J, Pullyblank AM, Avery KN, Brookes ST, Thomas MG, Sylvester PA, Russell A, Oliver A, Morton D, Kennedy R, Jayne DG, Huxtable R, Hackett R, Dutton SJ, Coleman MG, Card M, Brown J, Blazeby JM.

PLoS Med. 2016 Aug 9;13(8):e1002071. doi: 10.1371/journal.pmed.1002071. eCollection 2016 Aug.

9.

Trial outcomes and information for clinical decision-making: a comparative study of opinions of health professionals.

McNair AG, Brookes ST, Whistance RN, Forsythe RO, Macefield R, Rees J, Jones J, Smith G, Pullyblank AM, Avery KN, Thomas MG, Sylvester PA, Russell A, Oliver A, Morton D, Kennedy R, Jayne DG, Huxtable R, Hackett R, Dutton SJ, Coleman MG, Card M, Brown J, Blazeby JM; CONSENSUS-CRC (Core Outcomes and iNformation SEts iN SUrgical Studies – ColoRectal Cancer) working group.

Trials. 2016 Jul 25;17(1):344. doi: 10.1186/s13063-016-1492-0.

10.

What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges.

Daykin A, Selman LE, Cramer H, McCann S, Shorter GW, Sydes MR, Gamble C, Macefield R, Lane JA, Shaw A.

Trials. 2016 Jul 1;17(1):307. doi: 10.1186/s13063-016-1425-y.

11.

A Systematic Review of Patient-reported Outcomes in Randomized Controlled Trials of Unplanned General Surgery.

Stevens DJ, Blencowe NS, McElnay PJ, Macefield RC, Savović J, Avery KN, Blazeby JM.

World J Surg. 2016 Feb;40(2):267-76. doi: 10.1007/s00268-015-3292-1. Review.

12.

Core information set for oesophageal cancer surgery.

Blazeby JM, Macefield R, Blencowe NS, Jacobs M, McNair AG, Sprangers M, Brookes ST; Research Group of the Core Outcomes and iNformation SEts iN SUrgical Studies-Oesophageal Cancer; Consensus Group of the Core Outcomes and iNformation SEts iN SUrgical Studies-Oesophageal Cancer.

Br J Surg. 2015 Jul;102(8):936-43. doi: 10.1002/bjs.9840. Epub 2015 May 18.

PMID:
25980524
13.

Delphi survey to identify topics to be addressed at the initial follow-up consultation after oesophageal cancer surgery.

Jacobs M, Henselmans I, Macefield RC, Blencowe NS, Smets EM, de Haes JC, Sprangers MA, Blazeby JM, van Berge Henegouwen MI.

Br J Surg. 2014 Dec;101(13):1692-701. doi: 10.1002/bjs.9647. Epub 2014 Oct 15.

PMID:
25319127
14.

Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs).

Macefield RC, Jacobs M, Korfage IJ, Nicklin J, Whistance RN, Brookes ST, Sprangers MA, Blazeby JM.

Trials. 2014 Feb 5;15:49. doi: 10.1186/1745-6215-15-49. Review.

15.

Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery.

Jacobs M, Macefield RC, Elbers RG, Sitnikova K, Korfage IJ, Smets EM, Henselmans I, van Berge Henegouwen MI, de Haes JC, Blazeby JM, Sprangers MA.

Qual Life Res. 2014 May;23(4):1155-76. doi: 10.1007/s11136-013-0576-5. Epub 2013 Dec 3.

PMID:
24293086
16.

Selecting and measuring optimal outcomes for randomised controlled trials in surgery.

Macefield RC, Boulind CE, Blazeby JM.

Langenbecks Arch Surg. 2014 Mar;399(3):263-72. Review.

17.

Psychological impact of prostate biopsy: physical symptoms, anxiety, and depression.

Wade J, Rosario DJ, Macefield RC, Avery KN, Salter CE, Goodwin ML, Blazeby JM, Lane JA, Metcalfe C, Neal DE, Hamdy FC, Donovan JL.

J Clin Oncol. 2013 Nov 20;31(33):4235-41. doi: 10.1200/JCO.2012.45.4801. Epub 2013 Oct 21.

PMID:
24145343
18.

Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery.

Jacobs M, Macefield RC, Elbers RG, Sitnikova K, Korfage IJ, Smets EM, Henselmans I, van Berge Henegouwen MI, de Haes JC, Blazeby JM, Sprangers MA.

Qual Life Res. 2014 May;23(4):1097-115. doi: 10.1007/s11136-013-0545-z. Epub 2013 Oct 16. Review.

PMID:
24129668
19.

A prospective study of patient reported outcomes in pancreatic and peri-ampullary malignancy.

Rees JR, Macefield RC, Blencowe NS, Alderson D, Finch-Jones MD, Blazeby JM.

World J Surg. 2013 Oct;37(10):2443-53. doi: 10.1007/s00268-013-2104-8.

PMID:
23716026
20.

A systematic review of on-site monitoring methods for health-care randomised controlled trials.

Macefield RC, Beswick AD, Blazeby JM, Lane JA.

Clin Trials. 2013 Feb;10(1):104-24. doi: 10.1177/1740774512467405. Review.

PMID:
23345308
21.

Integration of clinical and patient-reported outcomes in surgical oncology.

Macefield RC, Avery KN, Blazeby JM.

Br J Surg. 2013 Jan;100(1):28-37. doi: 10.1002/bjs.8989. Epub 2012 Nov 20. Review.

22.

Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer.

Jacobs M, Macefield RC, Blazeby JM, Korfage IJ, van Berge Henegouwen MI, de Haes HC, Smets EM, Sprangers MA.

Qual Life Res. 2013 Sep;22(7):1787-803. doi: 10.1007/s11136-012-0290-8. Epub 2012 Oct 20. Review.

PMID:
23086534
23.

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.

Macefield RC, Metcalfe C, Lane JA, Donovan JL, Avery KN, Blazeby JM, Down L, Neal DE, Hamdy FC, Vedhara K; ProtecT Study Group.

Br J Cancer. 2010 Apr 27;102(9):1335-40. doi: 10.1038/sj.bjc.6605648. Epub 2010 Apr 6.

24.

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?

Macefield RC, Lane JA, Metcalfe C, Down L, Neal DE, Hamdy FC, Donovan JL.

Eur J Cancer. 2009 Sep;45(14):2569-73. doi: 10.1016/j.ejca.2009.03.016. Epub 2009 Apr 16.

PMID:
19375907

Supplemental Content

Loading ...
Support Center